VITILIGO: A COMPREHENSIVE REVIEW OF PATHOGENESIS, TYPES AND MANAGEMENT

作者
Supriya B. Sabale*1, Nikhita H. Bhosale2, Dhanashree R. Patil3, Sakshi M. Jakate4
出处
期刊:European journal of pharmaceutical and medical research [World Journal of Pharmacy and Pharmaceutical Sciences]
标识
DOI:10.5281/zenodo.18085365
摘要

Vitiligo is a chronic, multifactorial autoimmune disorder characterized by progressive loss of functional melanocytes, leading to depigmented macules and patches on the skin and mucosa. Affecting approximately 0.5–1% of the global population, vitiligo imposes significant psychosocial distress and remains a therapeutic challenge due to its complex and incompletely understood pathogenesis. Current evidence indicates that vitiligo arises from an intricate interplay of genetic predisposition, oxidative stress, immune dysregulation, and environmental triggers. Mitochondrial dysfunction, excessive oxidative stress, and impaired antioxidant defence initiate melanocyte damage, while autoreactive CD8⁺ T cells, altered CD4⁺/CD8⁺ ratios, and reduced regulatory T-cell (Treg) activity drive autoimmune destruction. Heat shock protein 70 (HSP70i) and proinflammatory cytokines such as IFN-γ and IL-17 amplify this immune cascade, culminating in melanocyte loss. Clinically, vitiligo presents in diverse forms—focal, segmental, acrofacial, generalized, universal, and mucosal—each with distinct distribution and prognostic implications. Diagnosis is primarily clinical but may be supported by laboratory and imaging modalities such as Wood’s lamp examination, digital photography, and point-counting techniques for disease assessment. Therapeutic approaches include topical corticosteroids, calcineurin inhibitors, vitamin D analogues, and phototherapy (NB-UVB, PUVA), with emerging options like Janus kinase (JAK) inhibitors, HSP70i gene therapy, and melanocyte-stimulating agents offering new hope. Despite recent advances, complete and sustained repigmentation remains elusive. Future directions emphasize the need for personalized, multimodal regimens targeting immune modulation, oxidative balance, and melanocyte regeneration. This comprehensive review explores the current understanding of vitiligo’s pathogenesis, classification, diagnostic strategies, and evolving management paradigms, highlighting promising innovations that may transform patient outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
pass发布了新的文献求助15
2秒前
wcychengyou完成签到,获得积分10
2秒前
2秒前
2秒前
完美世界的应助被涤宇采纳,获得10
3秒前
aaaaa发布了新的文献求助10
4秒前
zqy发布了新的文献求助10
4秒前
从容的发布了新的文献求助10
4秒前
溜溜心儿发布了新的文献求助10
4秒前
积极老四完成签到,获得积分10
5秒前
lmg完成签到,获得积分10
7秒前
8秒前
ghr777完成签到 ,获得积分10
8秒前
8秒前
123完成签到,获得积分20
8秒前
huanhuan发布了新的文献求助10
9秒前
SciGPT的应助被董晴采纳,获得10
9秒前
9秒前
xjh的应助被花样年华采纳,获得150
11秒前
11秒前
11秒前
gong完成签到,获得积分10
11秒前
巷阳完成签到,获得积分10
12秒前
丘比特的应助被RUI采纳,获得10
12秒前
赘婿的应助被王大橙子采纳,获得10
13秒前
威菡完成签到,获得积分10
13秒前
俊逸一手完成签到,获得积分10
13秒前
13秒前
华仔的应助被奋斗的凡采纳,获得10
13秒前
123发布了新的文献求助10
14秒前
14秒前
Sean发布了新的文献求助10
14秒前
Gloria2023发布了新的文献求助20
14秒前
li完成签到,获得积分10
14秒前
14秒前
传奇3的应助被1001采纳,获得10
15秒前
15秒前
涤宇发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148